Showing results (251-260 of 8,520) with videos related to

Sort By:
Pageof 852
Alimentary Pharmacology & Therapeutics|June 14, 2005
Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux diseaseD Castell, R Bagin, B Goldlust, et al.
Alimentary Pharmacology & Therapeutics|June 14, 2005
Postprandial oesophageal integrated acidity is a reliable predictor of gastro-oesophageal reflux diseaseG L Shih, C M Brensinger, D A Katzka, et al.
Alimentary Pharmacology & Therapeutics|May 11, 2005
Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trialE A Ott, L E Mazzoleni, M I Edelweiss, et al.
Alimentary Pharmacology & Therapeutics|May 11, 2005
Utility of the Health Belief Model in predicting compliance of screening in patients with chronic hepatitis BC-T Wai, M-L Wong, S Ng, et al.
Alimentary Pharmacology & Therapeutics|August 16, 2005
Review article: drug-induced microscopic colitis - proposal for a scoring system and review of the literatureL Beaugerie, D S Pardi
Alimentary Pharmacology & Therapeutics|August 16, 2005
Impact of precore and core promoter mutations on hepatic histology in patients with chronic hepatitis BH-J Yuan, M-F Yuen, D Ka-Ho Wong, et al.
Alimentary Pharmacology & Therapeutics|August 16, 2005
Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsiaB Adam, T Liebregts, K Saadat-Gilani, et al.
Alimentary Pharmacology & Therapeutics|September 1, 2005
The C-caffeine breath test distinguishes significant fibrosis in chronic hepatitis B and reflects response to lamivudine therapyG J-H Park, P H Katelaris, D B Jones, et al.
Alimentary Pharmacology & Therapeutics|September 1, 2005
Biliary secretion of moxifloxacin in obstructive cholangitis and the non-obstructed biliary tractD Schwab, M Grauer, E G Hahn, et al.
Alimentary Pharmacology & Therapeutics|September 1, 2005
Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurineM P Sparrow, S A Hande, S Friedman, et al.
Pageof 852